Drugs / TAT4 Gel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02647853 | Oct → Dec 2014 | lipodystrophy | Topokine Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAT4 Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02647853 ↗ |
| Route | Topical | “TAT4 Gel concentration A applied once daily to 50 cm2 for 14 days.” NCT02647853 ↗ |